Design and study protocol of the maternal smoking cessation during pregnancy study, (M-SCOPE)

Andriani N Loukopoulou, Constantine I Vardavas, George Farmakides, Christos Rossolymos, Charalambos Chrelias, Manolis N Tzatzarakis, Aristidis Tsatsakis, Maria Lymberi, Gregory N Connolly, Panagiotis K Behrakis, Andriani N Loukopoulou, Constantine I Vardavas, George Farmakides, Christos Rossolymos, Charalambos Chrelias, Manolis N Tzatzarakis, Aristidis Tsatsakis, Maria Lymberi, Gregory N Connolly, Panagiotis K Behrakis

Abstract

Background: Maternal smoking is the most significant cause of preventable complications during pregnancy, with smoking cessation during pregnancy shown to increase birth weight and reduce preterm birth among pregnant women who quit smoking. Taking into account the fact that the number of women who smoke in Greece has increased steadily throughout the previous decade and that the prevalence of smoking among Greek females is one of the highest in the world, smoking cessation should be a top priority among Greek health care professionals.

Methods/design: The Maternal Smoking Cessation during Pregnancy Study (M-SCOPE), is a Randomized Control Trial (RCT) that aims to test whether offering Greek pregnant smokers a high intensity intervention increases smoking cessation during the third trimester of pregnancy, when compared to a low intensity intervention. Prospective participants will be pregnant smokers of more than 5 cigarettes per week, recruited up to the second trimester of pregnancy. Urine samples for biomarker analysis of cotinine will be collected at three time points: at baseline, at around the 32nd week of gestation and at six months post partum. The control group/low intensity intervention will include: brief advice for 5 minutes and a short leaflet, while the experimental group/intensive intervention will include: 30 minutes of individualized cognitive-behavioural intervention provided by a trained health professional and a self-help manual especially tailored for smoking cessation during pregnancy, while counselling will be based on the ''5 As.'' After childbirth, the infants' birth weight, gestational age and any other health related complications during pregnancy will be recorded. A six months post-partum a follow up will be performed in order to re-assess the quitters smoking status.

Discussion: If offering pregnant smokers a high intensity intervention for smoking cessation increases the rate of smoking cessation in comparison to a usual care low intensity intervention in Greek pregnant smokers, such a scheme if beneficial could be implemented successfully within clinical practice in Greece.

Trial registration: ClinicalTrials.gov Identifier NCT01210118.

Figures

Figure 1
Figure 1
Study Design Flowchart.

References

    1. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package. Geneva, Switzerland; 2008.
    1. Hayashi Τ. In: UICC smoking control workshop. Suketami Tominanga, Kunio Aoki, editor. University of Nagoya Press Nagoya, Japan; 1979. Legislation and antismoking social attitudes in Japan.
    1. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Doll J, Doll R. Mortality from smoking worldwide. Brit Med Bul. 1996;52(suppl 1):12–21.
    1. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control. 2004;13:388–395. doi: 10.1136/tc.2003.005215.
    1. Centers for Disease Control and Prevention. Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses--United States, 1997-2001. MMMR. 2002;51(suppl 14):300–303.
    1. McGinnis J, Foege WH. Actual Causes of Death in the United States. JAMA. 1993;270:2207–2212. doi: 10.1001/jama.1993.03510180077038.
    1. Jacobs R. In: Women and the Tobacco Epidemic. Challenges for the 21st Century. Samet JM, Yoon S-Y, editor. World Health Organization Geneva, Switzerland; 2001. Economic policies, taxation and fiscal measures; pp. 177–200.
    1. Εrshoff DH, Ashford TH, Goldenberg RL. Helping pregnant women quit smoking: An overview. Nicotine Tob Res. 2004;6(Suppl 2):101–105.
    1. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ. 1987;65:663–737.
    1. Kleinman J, Pierre MJ, Madans J, Land G, Schramm W. The effects of maternal smoking on fetal and infantmortality. Am J Epidemiol. 1988;127:274–82.
    1. Ventura SJ, Martin JA, Taffel SM, Mathews TJ, Clarke SC. Advance report of final natality statistics, 1993. Monthly Vital Stat Rep. 1995;44(suppl 5):1–88.
    1. Creatsas G. In: Obstetrics. Paschalidis PH: Athens, editor. 1998. Modern obstetrics and gynecology; pp. 162–280.
    1. Simpson WJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol. 1957;73:4:808.
    1. Hofhuis W, de Jongste JC, Merkus PJF. Adverse health effects of prenatal and postnatal tobacco smoke exposure on children. Arch Dis Child. 2003;88:1086–1090. doi: 10.1136/adc.88.12.1086.
    1. United Nations: Convention of United Nations on the Rights of Child. New York; 1989.
    1. U.S. Department of Health and Human Services. Women and Smoking: A Report of the Surgeon General. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General. Washington; 2001.
    1. Barker D, Osmond C, Simmonds SJ, Wield GA. The relation of head size and thinness at birth to death from cardiovascular disease in adult life. BMJ. 1993;306:422–426. doi: 10.1136/bmj.306.6875.422.
    1. Gavin NI, Wiesen C, Layton C. Final Report to the National Center for Chronic Disease Prevention and Health Promotion. Research Triangle Institute, RTI Project No. 7171-010. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta; 2001. Review and Meta-Analysis of the Evidence on the Impact of Smoking on Perinatal Conditions Built into SAMMEC II.
    1. American Academy of Pediatrics: Task Force on Sudden Infant Death Syndrome. The Changing Concept of Sudden Infant Death Syndrome: Diagnostic Coding Shifts; Controversies Regarding the Sleeping Environment; and New Variables to Consider in Reducing Risk. Pediatrics. 2005;116:1245–1255.
    1. Stick SM, Burton PR, Gurrin L, Sly PD, LeSoeuf PN. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet. 1996. pp. 1060–1064.
    1. Dezateux C, Stocks J. Lung development and early origins of childhood respiratory illness. Brit Med Bul. 1997;53:40–57.
    1. Hoo A, Henschen M, Dezateux C, Costeloe K, Stocks J. Respiratory Function Among Preterm Infants Whose Mothers Smoked During Pregnancy. Am J Respir Crit Care Med. 1998;158(Suppl 3):700–705.
    1. Alati R, Al Mamun A, O'Callaghan M, Najman JM, Williams GM. In utero and postnatal maternal smoking and asthma in adolescence. Epidemiology. 2006;17:138–44. doi: 10.1097/01.ede.0000198148.02347.33.
    1. Bisgaard H, Dalgaard P, Nyboe J. Risk factors for wheezing during infancy. Acta Paediatr Scand. 1987;76:719–726. doi: 10.1111/j.1651-2227.1987.tb10555.x.
    1. Lumley J, Oliver SS, Chamberlain C, Oakley L. Cochrane Database Syst Rev. Suppl 4. Vol. 18. Review. John Wiley & Sons Ltd, Chichester, UK; 2004. Interventions for promoting smoking cessation during pregnancy; p. CD001055.
    1. Centers for Disease Control and Prevention. Cigarette Smoking-Attributable Mortality and Years of Potential Life Lost--United States. MMMR. 1993;42(Suppl 33):645–649.
    1. U. S Department of Health and Human Services. The Health Benefits of Smoking Cessation. A report of the Surgeon General. Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Atlanta: Georgia; 1990.
    1. Lumley J, Chamberlain C, Dowswell T, The Cohrane Library. Vol. 3. John Wiley & Sons Ltd. Chichester: UK; 2009. Interventions for promoting smoking cessation during pregnancy.
    1. Marks JS, Koplan JP, Hogue CJ, Dalmat ME. Cost-benefit/cost c effectiveness analysis of smoking cessation for pregnant women. AJPM. 1990;6(Suppl 5):282–9.
    1. Lightwood JM, Phibbs C, Glantz SA. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics. 1999;104(Suppl 6):1312–20.
    1. Wisborg K, Henriksen TB, Obel C, Skajaa E, Ostergaard JR. Smoking during pregnancy and hospitalization of the child. Pediatrics. 1999;104(Suppl 4):e46.
    1. Solomon LJ, Quinn VP. Spontaneous quitting: Self-initiated smoking cessation in early pregnancy. Nicotine Tob Res. 2004;6(Suppl 2):S203–S216.
    1. Fiore MC, Jaén CR, Baker TB, A Public Health Service Report. Rockville, MD: U.S. Department of Health and Human Services; Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline.
    1. Coleman GJ, Joyce T. Trends before, during and after pregnancy in ten states. Am J Prev Med. 2003;24(Suppl 1):29–35.
    1. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18:156–70. doi: 10.1093/her/18.2.156.
    1. Hajek P, West R, Lee A Foulds J, Owen L, Eiser JR, Main N. Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction. 2001;96:485–494. doi: 10.1046/j.1360-0443.2001.96348511.x.
    1. Moore LO, Campbell R, Whelan A, Mills N, Lupton P, Misselbrook E Frohlich J. Self help smoking cessation in pregnancy: cluster randomised controlled trial. BMJ. 2002;325:1383–6. doi: 10.1136/bmj.325.7377.1383.
    1. Bakker M. PhD thesis. Maastricht Health Research Institute for Prevention and Care. Netherlands; 2001. Pregnancy: a window of opportunity to quit smoking!! The development, implementation and evaluation of a minimal intervention strategy for pregnant women and partners.
    1. Walsh RA, Redman S, Brinsmead MW, Byrne JM, Melmeth A. Α smoking cessation program at a public antenatal clinic. Am J Public Health. 1997;87:1201–4. doi: 10.2105/AJPH.87.7.1201.
    1. Hegaard H, Hjaergaard H, Moller L, Wachmann H, Ottesen B. Multimodel intervention raises smoking cessation rate during pregnancy. Acta Obstetricia et Gynecologica Scandinavica. 2003;82:813–819. doi: 10.1034/j.1600-0412.2003.00221.x.
    1. Windsor RΑ. pregnant woman's guide to quit smoking. 5. Society for Public Health Education. Washington; 1985.
    1. Donatelle RJ, Prows SL, Champeau D, Hudson D. Randomised controlled trial using social support and financial incentives for high risk pregnant smokers: Significant Other Supporter (SOS) program. Tob Control. 2000;9(Suppl 3):67–9.
    1. Thornton L. Smoking and pregnancy: feasibility and effectiveness of a smoking intervention programme among pregnant women. Dept of Public Health, Dublin; 1997.
    1. Windsor RA, Woodby L, Miller T, Hardin J, Crawford M, DiClemente CC. Effectiveness of agency for health care policy and research clinical practice guideline and patient education methods for pregnant smokers in medicaid maternity care. Am J Obstetrics and Gynecology. 2000;182:68–75. doi: 10.1016/S0002-9378(00)70492-3.
    1. Οrganization for Economic Co-Operation and Development. Health at a Glance 2007: OECD Indicators.
    1. Vardavas C, Athanasopoulos D, Balomenaki E, Niaounaki D, Linardakis M, Kafatos A. Smoking habits of Greek preschool children's parents. BMC Public Health. 2007;7:112. doi: 10.1186/1471-2458-7-112.
    1. Pilali Μ. National Status Report, Euro- Scip III: Greece. 2006.
    1. Kyrlesi A, Soteriades ES, Warren CW, Kremastinou J, Papastergiou P, Jones NR, Hadjichristodoulou Ch. Tobacco use among students aged 13-15 years in Greece: the GYTS project. BMC Public Health. 2007;7:3. doi: 10.1186/1471-2458-7-3.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) Washington D.C; 1994.
    1. Goldberg DP. Manual of the General Health Questionnaire. Windsor. England: NFER-Nelson; 1978.
    1. Garyallos G, Karastergiou A, Adamopoulou A, Moutzoukis C, Alagiozidou E, Mala D, Garyfallos A. Greek version of General Health Questionnaire: accuracy of translation and validity. Acta Psychiatrica Scandinavica. 1991;84(Suppl 4):371–378.
    1. Fagerstrom KO. In: Smoking as a cardiovascular risk factor -New strategies for smoking cessation. Wilhelmsen L, editor. New York: Hogrefe and Huber Publishers; 1991. How to measure nicotine dependence.
    1. Glynn TJ, Manley MW, Pechacek TF. Physician-initiated smoking cessation program: the National Cancer Institute trials. Prog Clin Biol Res. 1990;339:11–25.
    1. American College of Obstetricians and Gynecologists. Committee Opinion No. 471. Smoking cessation during pregnancy. Obstet Gynecol. 2010;116:1241–4. doi: 10.1097/AOG.0b013e3182004fcd.
    1. Lancaster T, Stead L. Self-help interventions for smoking cessation. Cochrane Database Syst Rev. 2005;3:CD001118.
    1. Ferreira-Borges C. Effectiveness of a brief counseling and behavioral intervention for smoking cessation in pregnant women. Prev Med. 2005;41:295–302. doi: 10.1016/j.ypmed.2004.11.013.
    1. Lawrence T, Aveyard P, Evans O, Cheng KK. A cluster randomised controlled trial of smoking cessation in pregnant women comparing interventions based on the transtheoretical (stages of change) model to standard care. Tob Control. 2003;12:168–177. doi: 10.1136/tc.12.2.168.
    1. Gielen AC, Windsor R, Faden RR, O'Campo P, Repke J, Davis M. Evaluation of a smoking cessation intervention for pregnant women in an urban prenatal clinic. Health Educ Res. 1997;12(Suppl 2):247–254.
    1. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: A randomized controlled study. Bull World Health Organ. 2000;96(Suppl 6):967–971.
    1. Windsor R, Woodby L, Crawford M, Hardin M, Miller T, Decremented C. Effectiveness and cost benefit of the smoking cessation or reduction in pregnancy treatment model in Medicaid maternity care. Am J Public Health. 2001;129(Suppl 1):246–289.
    1. Greaves L, Barr V. Filtered policy: Women and tobacco in Canada. BC Centre of Excellence for Women's Health. Manitoba, Canada; 2000.
    1. Dunkley J. Training midwives to help pregnant women stop smoking. Nurs Times. 1997;93:64–66.
    1. Centers for Disease Control and Prevention. Surgeons' General Report-Within 20 minutes of quitting. Atlanta, USA; 2004.
    1. Webb DA, Boyd NR, Messina D, Windsor RA. The discrepancy between selfreported smoking status and urine cotinine levels among women enrolled in prenatal care at four publicly funded clinical sites. J Public Health Manag Pract. 2003;9:322–325.
    1. EPA California. Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant. Sacramento, CA; 2004.
    1. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18:188–204.
    1. Acosta M, Buchhalter A, Breland A, Hamilton DCP, Eissenberg T. Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips. Nicotine Tob Res. 2004;6:615–620. doi: 10.1080/14622200410001727867.
    1. Binnie V, McHugh S, Macpherson L, Borland B, Moir K, Malik K. The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine. Oral Diseases. 2004;10(Suppl 5):287–293.
    1. Miller EI, Norrisa HK, Rollins DE, Tiffany T, Wilkins DG. A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr B. 2010;878:725–737. doi: 10.1016/j.jchromb.2009.12.018.
    1. Nakajima M, Fukami T, H Yamanaka E, Higashi H, Sakai R, Yoshida Kwon JT, McLeod HL, Yokoi T. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther. 2006;80(Suppl 3):282–297.
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–12. doi: 10.1001/jama.1995.03520290060030.
    1. World Medical Association. Declaration of Helsinki. Helsinki, Finland; 1964.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera